Molecular determinants of A-site mRNA cleavage during ribosome pausing

核糖体暂停期间 A 位 mRNA 裂解的分子决定因素

基本信息

项目摘要

DESCRIPTION (provided by applicant): All cells, from bacterial to human, use ribosome pausing as a general strategy to regulate protein expression. Regulated ribosome pausing appears to be particularly common during the synthesis of proteins that are important for controlling cell growth and preventing cancer. The long-term goal is to understand how some paused ribosomes elicit a unique ribonuclease activity that cleaves messenger RNA (mRNA) in a position corresponding to the ribosome A-site. This A-site cleavage activity destabilizes mRNAs and may represent a novel mechanism of gene regulation. The specific hypothesis is that the newly-synthesized nascent protein elicits a ribosome arrest, which induces the ribosome to catalyze A-site mRNA cleavage. The hypothesis is based on the observations that 1) A-site mRNA cleavage requires specific nascent peptide sequences, 2) the ribosome and translational pausing are required for mRNA cleavage, and 3) the ribosome usually protects A-site mRNA from ribonucleases. Based on these observations, the experimental focus of this proposal is to determine the molecular requirements of A-site mRNA cleavage. The specific aims are to: 1. Determine the substrate requirements for A-site mRNA cleavage. Nascent peptide sequences will be screened for those that support efficient cleavage, and A-site codon sequence specificity will be determined. 2. Identify ribosomal components that are important for A-site mRNA cleavage. Ribosomal RNA is critical for decoding A-site mRNA. Ribosomal RNA is hypothesized to play an important role in the cleavage of the A- site codon during translational pause events. Known mutations and antibiotics that modulate the fidelity of ribosome decoding will be studied for effects on A-site mRNA cleavage. In addition, directed and unbiased mutagenic approaches will be used to produce ribosome variants that have altered A-site cleavage properties. 3. Reconstitute the A-site mRNA cleavage reaction in vitro. If the ribosome catalyzes A-site cleavage, then it should be possible to reconstitute the A-site cleavage reaction in a defined in vitro translation system comprised of highly-purified components. If the ribosome does not catalyze A-site mRNA cleavage, the defined translation system will be used in a biochemical approach to identify the trans-acting A-site nuclease.
描述(由申请人提供):所有细胞,从细菌到人类,都使用核糖体暂停作为调节蛋白质表达的一般策略。在控制细胞生长和预防癌症的重要蛋白质合成过程中,受调节的核糖体暂停似乎特别常见。长期目标是了解一些暂停的核糖体如何引发独特的核糖核酸酶活性,将信使RNA (mRNA)切割到与核糖体a位点对应的位置。这种a位点的裂解活性破坏了mrna的稳定性,可能代表了一种新的基因调控机制。具体的假设是,新合成的新生蛋白引起核糖体阻滞,核糖体阻滞诱导核糖体催化a位点mRNA裂解。该假设基于以下观察:1)A-site mRNA的切割需要特定的新生肽序列;2)mRNA的切割需要核糖体和翻译停顿;3)核糖体通常保护A-site mRNA免受核糖核酸酶的攻击。基于这些观察结果,本课题的实验重点是确定a位点mRNA切割的分子要求。具体目标是:1。确定a位点mRNA切割所需的底物。新生肽序列将筛选支持有效切割的肽序列,并确定a位点密码子序列的特异性。2. 鉴定对a位点mRNA切割有重要作用的核糖体成分。核糖体RNA对解码a位点mRNA至关重要。假设核糖体RNA在翻译暂停事件中对A位点密码子的切割起重要作用。已知的突变和抗生素调节核糖体解码的保真度将研究对a位点mRNA切割的影响。此外,定向和无偏诱变方法将用于产生改变a位点切割特性的核糖体变体。3. 体外重建a位点mRNA裂解反应。如果核糖体催化了a位点的裂解,那么在由高度纯化的组分组成的定义的体外翻译系统中应该可以重建a位点的裂解反应。如果核糖体不催化a位点mRNA的裂解,则定义的翻译系统将用于生化方法来识别反式作用的a位点核酸酶。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Christopher S. Hayes其他文献

Advanced glycation end-product crosslinking activates a type VI secretion system phospholipase effector protein
晚期糖基化终末产物交联激活 VI 型分泌系统磷脂酶效应蛋白
  • DOI:
    10.1038/s41467-024-53075-x
  • 发表时间:
    2024-10-11
  • 期刊:
  • 影响因子:
    15.700
  • 作者:
    Steven J. Jensen;Bonnie J. Cuthbert;Fernando Garza-Sánchez;Colette C. Helou;Rodger de Miranda;Celia W. Goulding;Christopher S. Hayes
  • 通讯作者:
    Christopher S. Hayes

Christopher S. Hayes的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Christopher S. Hayes', 18)}}的其他基金

Molecular Mechanisms of anti-bacterial contact-dependent growth inhibition (CDI)
接触依赖性生长抑制(CDI)抗菌的分子机制
  • 批准号:
    9207766
  • 财政年份:
    2016
  • 资助金额:
    $ 15.35万
  • 项目类别:
Molecular Mechanisms of anti-bacterial contact-dependent growth inhibition (CDI)
接触依赖性生长抑制(CDI)抗菌的分子机制
  • 批准号:
    10115747
  • 财政年份:
    2016
  • 资助金额:
    $ 15.35万
  • 项目类别:
Molecular Mechanisms of anti-bacterial contact-dependent growth inhibition (CDI)
接触依赖性生长抑制(CDI)抗菌的分子机制
  • 批准号:
    10360608
  • 财政年份:
    2016
  • 资助金额:
    $ 15.35万
  • 项目类别:
Molecular Mechanisms of anti-bacterial contact-dependent growth inhibition (CDI)
接触依赖性生长抑制(CDI)抗菌的分子机制
  • 批准号:
    10588224
  • 财政年份:
    2016
  • 资助金额:
    $ 15.35万
  • 项目类别:
Molecular determinants of A-site mRNA cleavage during ribosome pausing
核糖体暂停期间 A 位 mRNA 裂解的分子决定因素
  • 批准号:
    8500345
  • 财政年份:
    2006
  • 资助金额:
    $ 15.35万
  • 项目类别:
Molecular determinants of A-site mRNA cleavage during ribosome pausing
核糖体暂停期间 A 位 mRNA 裂解的分子决定因素
  • 批准号:
    7643347
  • 财政年份:
    2006
  • 资助金额:
    $ 15.35万
  • 项目类别:
Molecular determinants of A-site mRNA cleavage during ribosome pausing
核糖体暂停期间 A 位 mRNA 裂解的分子决定因素
  • 批准号:
    7880817
  • 财政年份:
    2006
  • 资助金额:
    $ 15.35万
  • 项目类别:
Molecular determinants of A-site mRNA cleavage during ribosome pausing
核糖体暂停期间 A 位 mRNA 裂解的分子决定因素
  • 批准号:
    7251518
  • 财政年份:
    2006
  • 资助金额:
    $ 15.35万
  • 项目类别:
Molecular determinants of A-site mRNA cleavage during ribosome pausing
核糖体暂停期间 A 位 mRNA 裂解的分子决定因素
  • 批准号:
    8690897
  • 财政年份:
    2006
  • 资助金额:
    $ 15.35万
  • 项目类别:
Molecular determinants of A-site mRNA cleavage during ribosome pausing
核糖体暂停期间 A 位 mRNA 裂解的分子决定因素
  • 批准号:
    8324585
  • 财政年份:
    2006
  • 资助金额:
    $ 15.35万
  • 项目类别:

相似海外基金

Disrupting Dogma: Investigating LPS Biosynthesis Inhibition as an Alternative Mechanism of Action of Aminoglycoside Antibiotics
颠覆教条:研究 LPS 生物合成抑制作为氨基糖苷类抗生素的替代作用机制
  • 批准号:
    10653587
  • 财政年份:
    2023
  • 资助金额:
    $ 15.35万
  • 项目类别:
Shaping Next Generation Aminoglycoside Antibiotics for Treatment of Multidrug-Resistant Diseases
打造下一代氨基糖苷类抗生素治疗多重耐药性疾病
  • 批准号:
    10585038
  • 财政年份:
    2023
  • 资助金额:
    $ 15.35万
  • 项目类别:
Creation of Next-generation Aminoglycoside Antibiotics Active against Multidrug-resistant Gram-negative Bacteria
开发对多重耐药革兰氏阴性菌具有活性的下一代氨基糖苷类抗生素
  • 批准号:
    20K06982
  • 财政年份:
    2020
  • 资助金额:
    $ 15.35万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Shaping Next Generation Aminoglycoside Antibiotics for Treatment of Multidrug- Resistant Diseases
打造下一代氨基糖苷类抗生素治疗多重耐药性疾病
  • 批准号:
    9934590
  • 财政年份:
    2019
  • 资助金额:
    $ 15.35万
  • 项目类别:
Combating Antibiotic Resistance to Aminoglycoside Antibiotics through Chemical Synthesis
通过化学合成对抗氨基糖苷类抗生素的耐药性
  • 批准号:
    392481159
  • 财政年份:
    2017
  • 资助金额:
    $ 15.35万
  • 项目类别:
    Research Fellowships
Shaping Next Generation Aminoglycoside Antibiotics for Treatment of Multidrug-Resistant Diseases
打造下一代氨基糖苷类抗生素治疗多重耐药性疾病
  • 批准号:
    9082038
  • 财政年份:
    2016
  • 资助金额:
    $ 15.35万
  • 项目类别:
Functional analysis of radical SAM enzymes involved in the biosynthesis of aminoglycoside antibiotics
氨基糖苷类抗生素生物合成中自由基SAM酶的功能分析
  • 批准号:
    26410174
  • 财政年份:
    2014
  • 资助金额:
    $ 15.35万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
EAPSI:Synthesis of Aminoglycoside Antibiotics
EAPSI:氨基糖苷类抗生素的合成
  • 批准号:
    1106886
  • 财政年份:
    2011
  • 资助金额:
    $ 15.35万
  • 项目类别:
    Fellowship Award
Preclinical evaluation of aminoglycoside antibiotics-derived amphiphiles (AADAs)
氨基糖苷类抗生素衍生的两亲物 (AADA) 的临床前评估
  • 批准号:
    185482
  • 财政年份:
    2009
  • 资助金额:
    $ 15.35万
  • 项目类别:
    Operating Grants
AMINOGLYCOSIDE ANTIBIOTICS FOR CYSTIC FIBROSIS
治疗囊性纤维化的氨基糖苷类抗生素
  • 批准号:
    6565399
  • 财政年份:
    2001
  • 资助金额:
    $ 15.35万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了